
Glimter MF 2mg/500mg Tablet SR
Marketer
Bluewaterresearch
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Glimter MF 2mg/500mg Tablet SR
DiaGlym SR tablets (2mg/500mg) are classified as antidiabetic medications, combining two agents to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. DiaGlym SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. The most frequent adverse effect is hypoglycemia (low blood sugar). Learn to recognize hypoglycemic symptoms – sweating, dizziness, headache, tremor – and how to treat them promptly. Consistent meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to track blood cell counts and liver function.
Primary Ingredients of Glimter MF 2mg/500mg Tablet SR
The provided text is "undefined," therefore no rewriting is possible.
Uses of Glimter MF 2mg/500mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glimter MF 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimter MF 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Take this extended-release tablet with a meal.
Common Side effects of Glimter MF 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimter MF 2mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimter MF 2mg/500mg Sustained-Release tablet should be taken with a meal.
How Glimter MF 2mg/500mg Tablet SR works:
Glimepiride/Metformin 2mg/500mg extended-release tablets (Glimter MF) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimter MF 2mg/500mg Tablet SR with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimter MF 2mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Glimter MF tablets (2mg/500mg) are contraindicated during lactation due to the potential for infant toxicity.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
For individuals with kidney impairment, Glimter MF 2mg/500mg SR tablets require careful administration. Dosage modification of Glimter MF 2mg/500mg SR tablets may be necessary. Physician consultation is advised. In cases of severe kidney disease, the use of Glimter MF 2mg/500mg SR tablets is contraindicated. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimter MF 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, a low initial dose is typically prescribed; the medication is unsuitable for individuals with severe hepatic dysfunction.
What if you forget to take Glimter MF 2mg/500mg Tablet SR :
Should you forget to take a Glimter MF 2mg/500mg Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimter MF 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Medication for diabetes |
